These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12907455)

  • 1. Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma.
    Portis T; Dyck P; Longnecker R
    Blood; 2003 Dec; 102(12):4166-78. PubMed ID: 12907455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.
    Anderson LJ; Longnecker R
    Blood; 2009 Jan; 113(1):108-16. PubMed ID: 18815281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
    Portis T; Longnecker R
    Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
    Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
    Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus LMP2A utilizes Syk and PI3K to activate NF-κB in B-cell lymphomas to increase MIP-1α production.
    Incrocci R; McAloon J; Montesano M; Bardahl J; Vagvala S; Stone A; Swanson-Mungerson M
    J Med Virol; 2019 May; 91(5):845-855. PubMed ID: 30609049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.
    Vockerodt M; Morgan SL; Kuo M; Wei W; Chukwuma MB; Arrand JR; Kube D; Gordon J; Young LS; Woodman CB; Murray PG
    J Pathol; 2008 Sep; 216(1):83-92. PubMed ID: 18566961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
    Ma SD; Tsai MH; Romero-Masters JC; Ranheim EA; Huebner SM; Bristol JA; Delecluse HJ; Kenney SC
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival.
    Mancao C; Hammerschmidt W
    Blood; 2007 Nov; 110(10):3715-21. PubMed ID: 17682125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.
    Minamitani T; Ma Y; Zhou H; Kida H; Tsai CY; Obana M; Okuzaki D; Fujio Y; Kumanogoh A; Zhao B; Kikutani H; Kieff E; Gewurz BE; Yasui T
    Proc Natl Acad Sci U S A; 2017 May; 114(18):4751-4756. PubMed ID: 28351978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
    Guasparri I; Bubman D; Cesarman E
    Blood; 2008 Apr; 111(7):3813-20. PubMed ID: 18230756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1.
    Cader FZ; Vockerodt M; Bose S; Nagy E; Brundler MA; Kearns P; Murray PG
    Blood; 2013 Dec; 122(26):4237-45. PubMed ID: 24136166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development.
    Portis T; Longnecker R
    J Virol; 2003 Jan; 77(1):105-14. PubMed ID: 12477815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.
    Vrazo AC; Chauchard M; Raab-Traub N; Longnecker R
    PLoS Pathog; 2012; 8(4):e1002662. PubMed ID: 22536156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg cells. A morphometric analysis.
    Sandvej KB; Hamilton-Dutoit SJ; Pallesen G
    Leuk Lymphoma; 1993 Jan; 9(1-2):95-101. PubMed ID: 7682882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.
    Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M
    Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.
    Caldwell RG; Wilson JB; Anderson SJ; Longnecker R
    Immunity; 1998 Sep; 9(3):405-11. PubMed ID: 9768760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.
    Swanson-Mungerson M; Bultema R; Longnecker R
    J Gen Virol; 2010 Sep; 91(Pt 9):2197-202. PubMed ID: 20484564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis.
    Niedobitek G; Kremmer E; Herbst H; Whitehead L; Dawson CW; Niedobitek E; von Ostau C; Rooney N; Grässer FA; Young LS
    Blood; 1997 Aug; 90(4):1664-72. PubMed ID: 9269787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.